title: [Results of combined drug and radiotherapy in bronchial carcinoma].
abstract: 90 out of 191 patients with bronchial carcinomas were treated exclusively with telecobalt (focal dose ofer 4,500 rad), 78 patients were given an additional treatment with Proresid, and 23 patients were additionally treated with 5-fluorouracil under so-called synchronization conditions. As far as the Proresid is concerned, the combination with the chemotherapy did not bring about an amelioration of the survival rates compared to the results of the radiotherapy alone. The survival rate of the patients treated with cobalt 60 and with 5-fluorouracil even showed a considerable decrease, so that the described combination therapies are not longer used in our institute.
mesh_terms: D001984:Bronchial Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011033:Podophyllin / Q000627:therapeutic use; D011867:Radioisotope Teletherapy; D011879:Radiotherapy Dosage
chemical_list: D003037:Cobalt Radioisotopes; D011033:Podophyllin; D005472:Fluorouracil
vernacular_title: Ergebnisse einer kombinierten Chemo- und Strahlentherapie des Bronchialkarzinoms